This protocol involves the collection of apheresis products from HIV-1 infected individuals to evaluate strategies to decrease or target the latent reservoir using an ex vivo models and to evaluate the size and different measurement methodologies of the HIV reservoir. Apheresis product will be sent to collaborating institutions as requested.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:TBD, tbd, tbd
Age:
99 years or below
Gender: All
Updated on
27 Aug 2018.
Study ID: 829132
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code